These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23204182)

  • 21. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy.
    Costa GC; da Costa Rocha MO; Moreira PR; Menezes CA; Silva MR; Gollob KJ; Dutra WO
    J Infect Dis; 2009 Feb; 199(3):451-4. PubMed ID: 19099482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.
    Guedes PM; Gutierrez FR; Silva GK; Dellalibera-Joviliano R; Rodrigues GJ; Bendhack LM; Rassi A; Rassi A; Schmidt A; Maciel BC; Marin Neto JA; Silva JS
    PLoS Negl Trop Dis; 2012; 6(4):e1630. PubMed ID: 22545173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of aberrant T-cell responses in Chagas disease.
    DosReis GA; Freire-de-Lima CG; Nunes MP; Lopes MF
    Trends Parasitol; 2005 May; 21(5):237-43. PubMed ID: 15837613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease Tolerance and Pathogen Resistance Genes May Underlie
    Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E
    Front Immunol; 2018; 9():2791. PubMed ID: 30559742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Specific
    Gomes Dos Santos A; Watanabe EH; Ferreira DT; Oliveira J; Nakanishi ÉS; Oliveira CS; Bocchi E; Novaes CTG; Cruz F; Carvalho NB; Sato PK; Yamashiro-Kanashiro EH; Pontillo A; de Freitas VLT; Onuchic LF; Shikanai-Yasuda MA
    Front Immunol; 2020; 11():521409. PubMed ID: 33193300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total and specific anti-Trypanosoma cruzi immunoglobulin E in pericardial fluid samples from patients with chronic Chagas disease.
    Mineo JR; Rocha A; Costa-Cruz JM; da Silva AM; Silva DA; Goncalves-Pires MD; Lopes ER; Chapadeiro E
    Trans R Soc Trop Med Hyg; 1996; 90(5):578-81. PubMed ID: 8944279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
    Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
    Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of Cardiac IL-10 and Downregulation of IFN-
    da Silva MV; de Almeida VL; de Oliveira WD; Matos Cascudo NC; de Oliveira PG; da Silva CA; da Silva ACS; Dos Reis Monteiro MLG; Correa RRM; Oliveira MAP; Lino-Júnior RS; Celes MRN; Machado JR
    Mediators Inflamm; 2018; 2018():3421897. PubMed ID: 30622430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy.
    Corrêa MV; da Costa Rocha MO; de Sousa GR; do Carmo Pereira Nunes M; Gollob KJ; Dutra WO; da Silva Menezes CA
    Hum Immunol; 2013 Oct; 74(10):1375-81. PubMed ID: 23800435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.
    Scharfstein J; Gomes Jde A; Correa-Oliveira R
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():187-98. PubMed ID: 19753474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
    Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
    J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
    Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
    BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Mattoso-Barbosa AM; Gouin N; Perdigão-de-Oliveira M; Valério-Dos-Reis L; Costa RP; Elói-Santos SM; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; Dick EJ; Hubbard GB; VandeBerg JF; VandeBerg JL
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005233. PubMed ID: 28225764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease.
    Vasconcelos RH; Amaral FN; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2010 Oct; 71(10):964-7. PubMed ID: 20659514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.